FMC Reports Q1 2026 Results Above Guidance, Reaffirms Full-Year Outlook

FMC Corporation reported first quarter 2026 revenue of $759 million, down 4 percent year over year, with Adjusted EBITDA of $72 million, down 40 percent, as lower pricing and tariff-driven costs weighed on results. Price fell 6 percent, reflecting lower pricing to diamide partners, Rynaxypyr pricing actions and a competitive legacy core market in Latin America, while volume rose 2 percent and new active ingredient sales doubled. The company reaffirmed 2026 revenue excluding India of $3.60 billion to $3.80 billion and Adjusted EBITDA of $670 million to $730 million, and is pursuing a debt reduction of about $1 billion.

Key facts

Market context

FMC is an agricultural chemicals company, and its products are crop protection active ingredients used by growers and crop advisers to control insects, fungi and other pests in row crops, fruits, vegetables and specialty crops. Demand is driven by farm incomes, planting areas, pest pressure and the availability of generic alternatives. Diamide insecticides such as Rynaxypyr, a ryanodine receptor modulator, have been widely adopted, so pricing moves in that class tend to ripple through the sector as generic producers compete for share. Newer active ingredients typically carry premium pricing during their early commercial years, which makes growth in new actives important for margin mix. Lower average selling prices combined with tariff-related input costs compress profitability even when volumes rise, a pattern common across agrochemical makers. Buyers of crop protection intermediates and formulators should watch whether pricing pressure in legacy diamides persists and whether competitors respond with their own price adjustments.

Source: official release on fmc.com. Summary and context written by Market Krystal.